Ann: Positive preliminary results from ATL1102 DMD Phase II trial, page-125

I know that Diamond and the Anp Board we’re reluctant to put out “ Mickey Mouse” Announcements...
The DMD trial data was so compelling that they felt confident with releasing the preliminary results.
With Moses at the helm . A well respected Person in the Global Biotech World...a tough ringmaster was never one for putting out Announcements to appease shareholders..
My ComSec Buy/Sell acc has already lit up.. I guess it’s the overseas buyers who know the value $$$ of Biotechs..People: A $500 mill MC is on the cards in the short term however $1 billion MC is also achievable.. that’s $2 per share... (Innate got to $1.85 on nothing..)

Now Anp in the past announcement have highlighted the fact that Atl 1102 could be used in “Conjunction” with other drugs... The inflammation market is over $100 billion....Itsagas is telling the faithfuls not to sell early..